MILLER AINE (SVP, DEV & HEAD OF IRE OFFICE) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/22/2024ACC: 0001415889-24-027569
Officer· SVP, DEV & HEAD OF IRE OFFICE
Since Feb 2026
-10.08K
Net shares
Net seller
$100.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
10.08K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−10.08K
Price / share
$9.97
Trade value
$100.46K
% of position
6.3%
11/20/2024
160.63K→150.56K
Total
Net shares
−10.08K
Net value
-$100.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/20/2024 | F · Tax Withholding | −10.08K | $9.97 | $100.46K | 6.3% | 160.63K | 150.56K |
| Total | −10.08K | -$100.46K | ||||||
Derivative Transactions0
No derivative transactions reported